Hyderabad, Jan. 6 -- Pandorum Technologies, a regenerative medicine company, on Tuesday announced a strategic collaboration with Hyderabad-based Nucelion Therapeutics to strengthen manufacturing capabilities for its exosome-based regenerative therapies aimed at treating serious ocular diseases across the Asia-Pacific (APAC) region.
The collaboration is focused on accelerating the availability of next-generation treatments for patients suffering from debilitating and currently underserved eye conditions, including ocular surface injuries, inflammatory corneal diseases, Stevens-Johnson syndrome (SJS), and Neurotrophic Keratitis, the company said in a release.
These conditions often lead to chronic pain, vision loss, and reduced quality of l...